Heparin Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Global Heparin Market is Segmented by Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), and Ultra-Low Molecular Weight Heparin (ULMWH), Source (Bovine and Porcine), Application (Deep Vein Thrombosis (DVT), Atrial Fibrillation And Heart Attack, Coronary Artery Disease, And Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The report offers the value (in USD million) for all the above segments.

Heparin Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Heparin Market Size

Heparin Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 10.04 Billion
Market Size (2030) USD 14.16 Billion
CAGR (2025 - 2030) 7.12 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Heparin Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Heparin Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Heparin Market Analysis

The Global Heparin Market size is estimated at USD 10.04 billion in 2025, and is expected to reach USD 14.16 billion by 2030, at a CAGR of 7.12% during the forecast period (2025-2030).

The COVID-19 pandemic disrupted not only the research and development of treatments and medications for illnesses other than COVID-19 but also the global supply chain for pharmaceuticals, which in turn had an effect on the Anticoagulant Market, including Heparin, as well. But numerous researches have pointed to the advantages of Heparin for COVID-19 patients. For instance, according to an article published by Frontiers in August 2020, a large retrospective cohort study was conducted which showed lower mortality in COVID-19 patients treated with Heparin. It was also found that patients hospitalized with COVID-19 who received anticoagulation treatment with Heparin had a lower risk of mortality, even after adjusting for age and gender, a saturation of oxygen at 90%, temperature greater than 37°C, and use of concomitant medications. The Heparin Market had favorable growth during the early pandemic as a result of this factor. Currently, the market growth has slowed down as the COVID-19 pandemic subsided, and it is expected to have a stagnant growth during the forecast period of the study.

Heparin is an Anticoagulant medication that prevents blood clots from forming in patients with specific medical conditions or who are undergoing medical procedures that increase the risk of clot formation, such as surgery. Thus, the rising prevalence of chronic diseases such as cardiovascular disease, cancer, and others, and the attendant demand for more cutting-edge and efficient therapeutics, are anticipated to boost the Heparin Market and propel its development.

For instance, a research study published by PubMed in February 2021 stated that atrial fibrillation affects 37,574 million people worldwide (0.51 percent of the population) and that its prevalence has increased by 33 percent over the previous 20 years. The study further stated that the burden is greatest in countries with a high socio-demographic index, though the most recent growth has been in countries with a middling socio-demographic index. Additionally, according to the same source, the prevalence of atrial fibrillation could increase globally by more than 60% by 2050, which is anticipated to have a significant impact on the development of the market under study. As a result, the demand for Heparin is anticipated to increase, which will propel growth in the Global Heparin Market over the study's forecast period. The aging population, especially those over the age of 65, is another factor that is anticipated to have a significant impact on the growth of the Heparin Market. Long hospital stays, surgeries, and trauma can all increase the likelihood of developing a blood clot, so with an aging population, the studied market is expected to experience significant growth. For instance, the United Nations' World Population Ageing Highlight 2020 report found that the global geriatric population is growing quickly and that, in 2020, there were about 727 million people worldwide who were 65 or older, accounting for about 9.3 percent of the world's population overall. The same report also predicted that by the year 2050, there would be about 1.5 billion people in this age group, representing about a third of the world's population. Therefore, the aging population will have a big impact on the researched market's growth through time and fuel the Heparin Market's expansion.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For example, in January 2022, Ginkgo Bioworks and Optimvia teamed up to improve the manufacturing efficiency of non-animal-derived Lab-Synthesized Heparin that is commonly used as an Anticoagulant to help prevent blood clots. Hence, the product launches by key market players are expected to boost the market growth during the forecast period of the study.

Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the side effects of Heparin and the emergence of new and advanced oral coagulants may restrain the growth of the Heparin Anticoagulant Market during the forecast period of the study.

Heparin Industry Overview

The global Heparin Market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Some of the key companies include Aspen Pharmacare Holdings Limited, B Braun Melsungen AG, Baxter International Inc., Dr. Reddy's Laboratories, Hebei Changshan Biochemical Pharmaceutical, Leo Pharma AS, Opocrin SpA, Pfizer Inc, FRESENIUS KABI, GLAND PHARMA, HIKMA PHARMACEUTICALS, Techdow USA, Viatris Inc., Novartis AG, and Smiths Medical among others.

Heparin Market Leaders

  1. Opocrin SpA

  2. Baxter International

  3. Aspen Pharmacare Holdings Limited

  4. B Braun Melsungen AG

  5. Pfizer Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Heparin Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Heparin Market News

  • February 2022 : Techdow USA Inc. launched Heparin Sodium Injection in the United States market.
  • January 2022 : Ohio-based biotechnology company Optimvia Pharmaceuticals claimed to have developed a synthetic method for creating large quantities of heparin, which is needed to make a common blood thinner, at a reasonable price.

Heparin Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Rise in Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Side Effects of Heparin and Emergence of Oral Coagulants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product
    • 5.1.1 Unfractionated Heparin
    • 5.1.2 Low Molecular Weight Heparin (LMWH)
    • 5.1.3 Ultra-low Molecular Weight Heparin (ULMWH)
  • 5.2 By Source
    • 5.2.1 Bovine
    • 5.2.2 Porcine
  • 5.3 By Application
    • 5.3.1 Deep Vein Thrombosis (DVT)
    • 5.3.2 Atrial Fibrillation and Heart Attack
    • 5.3.3 Coronery Artery Disease
    • 5.3.4 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aspen Pharmacare Holdings Limited
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Baxter International Inc.
    • 6.1.4 Dr. Reddy's Laboratories
    • 6.1.5 Hebei Changshan Biochemical Pharmaceutical
    • 6.1.6 Leo Pharma AS
    • 6.1.7 Opocrin SpA
    • 6.1.8 Pfizer Inc.
    • 6.1.9 FRESENIUS KABI
    • 6.1.10 GLAND PHARMA
    • 6.1.11 HIKMA PHARMACEUTICALS
    • 6.1.12 Techdow USA
    • 6.1.13 Viatris Inc.
    • 6.1.14 Novartis AG
    • 6.1.15 Smiths Medical
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Heparin Industry Segmentation

As per the scope of the report, heparin is used as an anticoagulation agent that allows the body's natural clot lysis mechanisms to work normally to break down clots that have formed. The heparin market is segmented by product (unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH), source (bovine and porcine), application (deep vein thrombosis (DVT), atrial fibrillation and heart attack, coronary artery disease, and other applications), and by geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the value (in USD million) for all the above segments.

By Product Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-low Molecular Weight Heparin (ULMWH)
By Source Bovine
Porcine
By Application Deep Vein Thrombosis (DVT)
Atrial Fibrillation and Heart Attack
Coronery Artery Disease
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Heparin Market Research FAQs

How big is the Global Heparin Market?

The Global Heparin Market size is expected to reach USD 10.04 billion in 2025 and grow at a CAGR of 7.12% to reach USD 14.16 billion by 2030.

What is the current Global Heparin Market size?

In 2025, the Global Heparin Market size is expected to reach USD 10.04 billion.

Who are the key players in Global Heparin Market?

Opocrin SpA, Baxter International, Aspen Pharmacare Holdings Limited, B Braun Melsungen AG and Pfizer Inc. are the major companies operating in the Global Heparin Market.

Which is the fastest growing region in Global Heparin Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Heparin Market?

In 2025, the North America accounts for the largest market share in Global Heparin Market.

What years does this Global Heparin Market cover, and what was the market size in 2024?

In 2024, the Global Heparin Market size was estimated at USD 9.33 billion. The report covers the Global Heparin Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Heparin Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Heparin Industry Report

The Global Heparin Market is segmented by product, source, application, and geography. This industry report offers an in-depth market analysis, providing insights into market growth, market share, and market size. The market report covers various segments such as unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). It also explores sources like bovine and porcine, and applications including deep vein thrombosis (DVT), atrial fibrillation and heart attack, coronary artery disease, and other applications. The geographical segmentation includes North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

The industry analysis includes a market forecast outlook, historical overview, and market trends, offering a comprehensive view of the heparin market. The market leaders and market research data provide valuable insights into market dynamics. The industry reports highlight the market value and market segmentation, giving a detailed market overview. The report also includes industry statistics and industry size, offering a clear picture of the market landscape.

This market analysis is crucial for understanding the market growth and market predictions. The industry outlook and industry trends help in identifying the growth rate and market forecast. The report example and report PDF provide a detailed market review and market data, essential for industry research and understanding market dynamics. The research companies involved in this study offer valuable industry information and market outlook, making this report a vital resource for stakeholders in the heparin market.